Immunogenicity and safety of single booster dose of KD-414 inactivated COVID-19 vaccine in adults: An open-label, single-center, non-randomized, controlled study in Japan

Although vaccines for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) disease 2019 (COVID-19) induce effective immune responses, vaccination with booster doses is necessary because of waning immunity. We conducted an open-label, non-randomized, single-arm study in adults in Japan to ass...

Descripción completa

Detalles Bibliográficos
Autores principales: Terada-Hirashima, Junko, Takamatsu, Yuki, Shimizu, Yosuke, Uemura, Yukari, Takeuchi, Junko S., Tomita, Noriko, Matsuda, Kouki, Maeda, Kenji, Yamamoto, Shohei, Fukunaga, Ami, Ohmagari, Norio, Mikami, Ayako, Sonoda, Kengo, Ujiie, Mugen, Mitsuya, Hiroaki, Sugiura, Wataru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2023
Materias:
Coronavirus
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10114994/
https://www.ncbi.nlm.nih.gov/pubmed/37052247
http://dx.doi.org/10.1080/21645515.2023.2193074

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10114994/
https://www.ncbi.nlm.nih.gov/pubmed/37052247
http://dx.doi.org/10.1080/21645515.2023.2193074

Ejemplares similares